EW RSI

What is EW?

Edwards Lifesciences has a fascinating history that dates back to 1958 when Miles Lowell Edwards set out to build the first artificial heart. Partnering with Dr. Albert Starr, they created the Starr-Edwards valve, which effectively launched the modern era of heart valve replacement. The company eventually became part of Baxter International before spinning off as an independent entity in 2000. Since then, it has transformed from a niche surgical player into a dominant force in the global medtech industry.

Their business model is built around high-stakes, high-reward innovation. They do not try to be a generalist medical supplier; instead, they focus intensely on structural heart disease. The crown jewel of their portfolio is the SAPIEN family of transcatheter aortic valve replacement (TAVR) devices. TAVR changed the game by allowing doctors to replace heart valves through a catheter rather than performing invasive open-heart surgery. Beyond TAVR, they are heavily invested in Transcatheter Mitral and Tricuspid Therapies (TMTT) and surgical structural heart products.

Financially, Edwards is a powerhouse with top-tier margins, though they have seen some recent volatility as the TAVR market matures. They recently made a massive strategic move by divesting their Critical Care unit to Becton Dickinson to double down on their core heart therapies. This has cleaned up their balance sheet and sharpened their focus on high-growth cardiac segments.

Looking toward 2026, the strategy is all about expansion and indications. While TAVR remains the bread and butter, the real growth story is moving into TMTT, where they are chasing a multibillion-dollar opportunity in mitral and tricuspid repair. By 2026, we expect to see crucial data from clinical trials regarding asymptomatic aortic stenosis, which could significantly expand their addressable patient base. They are also aggressively scaling in Europe and Asia. If they can maintain their technological edge against competitors, they will remain the undisputed heavyweight in the structural heart space.

What is RSI?

The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and magnitude of price changes. Developed by J. Welles Wilder, RSI ranges from 0 to 100 and helps traders identify overbought or oversold conditions in an asset.

For EW, monitoring the RSI provides valuable insights into potential trend reversals and entry/exit points. When the RSI drops below 30, Edwards Lifesciences Corp is typically considered oversold, suggesting the asset may be undervalued. Conversely, an RSI above 70 indicates overbought conditions.

Understanding EW RSI Signals

• Oversold (RSI below 30): When EW RSI falls below 30, it suggests the asset may have been sold off excessively and could be due for a bounce. This is often viewed as a potential buying opportunity, though it's important to consider other factors and not rely solely on RSI.
• Overbought (RSI above 70): An RSI above 70 indicates EW may be overbought, potentially signaling a pullback or consolidation phase. Traders often use this as a signal to take profits or wait for better entry points.
• Divergences: When EW price makes new highs or lows but RSI doesn't confirm these moves, it can signal weakening momentum and a possible trend reversal.

Daily vs Weekly RSI for EW

This page displays both daily and weekly RSI for EW. The daily RSI responds quickly to short-term price movements, making it useful for day traders and swing traders. The weekly RSI provides a broader perspective on momentum trends, helping longer-term investors identify major oversold or overbought conditions.

By analyzing both timeframes together, you can better understand Edwards Lifesciences Corp's momentum at multiple levels and make more informed trading decisions.

Historical RSI Oversold Analysis

Above, we track historical instances when EW RSI dropped below 30 (oversold territory). Reviewing these past oversold levels helps identify patterns and understand how Edwards Lifesciences Corp has historically responded to oversold conditions. Many traders use these historical reference points to gauge potential support levels and timing for entry positions.